Latest Phenols Stories
BuTab, an Enteric-Coated Buprenorphine Product Candidate, to be Compared with Marketed Intravenous and Sublingual Formulations NEW YORK, Feb.
DUBLIN and RALEIGH, N.C., Feb.
Comprehensive market research report “Moderate to Severe Pain: Novel Abuse Deterrent Formulation Technologies and Emergence of Novel Mechanisms in the Management of Pain” elaborated by MP
NEWARK, Calif., Feb. 12, 2015 /PRNewswire/ -- Depomed, Inc.
TAMPA, Fla., Feb. 10, 2015 /PRNewswire/ -- Oxis International, Inc.
VALLEY COTTAGE, N.Y., Feb.
DUBLIN, Feb .04, 2015 /PRNewswire/ --Research and Markets
NEWARK, Calif., Feb. 4, 2015 /PRNewswire/ -- Depomed, Inc. (NASDAQ:DEPO) today announced that it will be presenting at two healthcare conferences in February.
SCOTTSDALE, Ariz., Feb.
USPTO awards patent for combination use of modified citrus pectin and honokiol extract, with potential to inhibit growth of numerous types of cancer SANTA ROSA, Calif., Feb.
- A woman chauffeur.
- A woman who operates an automobile.
More Images (1 images) »